Prospective individual patient data meta-analysis: evaluating convalescent plasma for COVID-19
From MaRDI portal
Publication:6628017
DOI10.1002/SIM.9115zbMATH Open1546.62265MaRDI QIDQ6628017
Keith S. Goldfeld, Thaddeus Tarpey, Yinxiang Wu, Andrea B. Troxel, Danni Wu, Eva Petkova, Mengling Liu
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
stopping rulesBayesian data and safety monitoringinternational consortium for data sharing from ongoing RCTsstatistical analysis plan
Cites Work
- Performance guarantees for individualized treatment rules
- A class of k-sample tests for comparing the cumulative incidence of a competing risk
- Checking the Cox model with cumulative sums of martingale-based residuals
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- Estimating Individualized Treatment Rules Using Outcome Weighted Learning
- Optimal Dynamic Treatment Regimes
- A constrained single‐index regression for estimating interactions between a treatment and covariates
- Constructing treatment decision rules based on scalar and functional predictors when moderators of treatment effect are unknown
This page was built for publication: Prospective individual patient data meta-analysis: evaluating convalescent plasma for COVID-19
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628017)